Newer studies that have come out do suggest that there is a real connection between thyroid cancer and the long-term use of GLP-1 agonists
Unlike endogenous GLP-1, which is rapidly degraded by dipeptidyl peptidase-4, GLP-1 receptor agonists are resistant to degradation and have longer half-lives, particularly for modern long-acting agents, such as liraglutide, dulaglutide, semaglutide and tirzepatide
However, those treated with GLP-1 RAs appear to have higher prevalence of late-diabetic complications and previous SU and insulin use
An accumulation of senescent cells in aging tissues, contribute to inflammation and disrupt the healthy functioning of hair follicles
Choosing a clean, plant-based antioxidant supplement lets you focus on looking and feeling your best
But as new telehealth companies promote their services, PAAB has alerted Health Canada to ads that seem to cross the line